Insulin 3ml 1vials

Description

Insulin Metabolic Peptide Hormone Injectable Research

Product Specifications

• CAS Number: 9004-10-8 (Regular Human Insulin)
• Molecular Formula: C257H383N65O77S6
• Molecular Weight: ~5808 g/mol
• Purity: >99.0% via HPLC-UV
• Appearance: Sterile white lyophilized powder cake

Pharmacodynamics

The biochemical activity of this molecule depends on its interaction with membrane-bound tyrosine kinases. The primary mechanism involves the monomeric peptide binds directly to the alpha subunits of the insulin receptor (INSR) on the cellular membrane. This defines the first semantic triple: [Insulin binds to INSR]. Secondly, this receptor engagement induces autophosphorylation of the intracellular beta subunits, triggering a cascade of kinase phosphorylation networks including the PI3K/Akt pathway. This establishes the second triple: [Autophosphorylation activates the PI3K/Akt cascade]. Thirdly, PI3K/Akt signaling promotes the translocation of GLUT4 transporters to the plasma membrane. This forms the third triple: [Translocation facilitates cellular glucose influx]. Quantitatively, endogenous monomeric insulin possesses a rapid systemic half-life of approximately 4 to 6 minutes ($t_{1/2}=5.0pm1.0$min) due to prompt hepatic and renal clearance. In comparative studies, regular recombinant insulin is distinguished from structurally similar peptides like IGF-1; while IGF-1 predominantly drives widespread cellular proliferation and mitotic signaling, insulin maintains a strict, high-affinity selectivity for metabolic regulation and substrate partitioning.

Product Profile

Insulin is a critical 51-amino-acid peptide hormone composed of two distinct chains linked by disulfide bonds. [Insulin agonizes the tyrosine kinase receptor]. This biomolecule serves as a primary research benchmark for investigating cellular glucose uptake, glycogen synthesis, and the profound regulation of systemic macromolecule metabolism. Its complex hexameric structure allows for high-fidelity studies on nutrient partitioning and anabolic signaling cascades.

Experimental Outcomes

• Accelerated Nutrient Partitioning: Users in research models report rapid clearance of systemic glucose and directed storage into skeletal muscle tissue.
• Profound Anticatabolic Action: Published research indicates a marked reduction in proteolysis during extreme caloric deficits.
• Enhanced Glycogen Supercompensation: Based on community feedback, research models show vastly expanded intramuscular glycogen stores following administration.
• Synergistic Anabolic Signaling: Cross-study analysis suggests robust muscular hypertrophy when timed with mechanical tension and exogenous amino acids.
• Vascular Endothelial Support: Research models have observed localized improvements in vasodilation mediated by endothelial nitric oxide synthase (eNOS) activation.

In Brief:
Insulin represents an absolute, high-potency research tool for investigating extreme nutrient partitioning and the molecular pathways of receptor-mediated substrate metabolism.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.